Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,012.63 -59.00 (-1.16%) Dow
37,863.78 -597.14 (-1.55%) Nasdaq
15,460.78 -251.97 (-1.60%) Bitcoin USD
64,075.18 -608.28 (-0.94%) CMC Crypto 200
1,382.45 -0.12 (-0.01%)
Clearside Biomedical, Inc. (CLSD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:38AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 100.13M |
| Enterprise value | 72.22M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.07 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 8.78 |
| Enterprise value/EBITDA | -3.13 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.33 |
| 52-week change 3 | 31.37% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 2.1200 |
| 52-week low 3 | 0.6500 |
| 50-day moving average 3 | 1.4477 |
| 200-day moving average 3 | 1.1481 |
Share statistics
| Avg vol (3-month) 3 | 370.52k |
| Avg vol (10-day) 3 | 269.09k |
| Shares outstanding 5 | 74.72M |
| Implied shares outstanding 6 | 74.72M |
| Float 8 | 69.15M |
| % held by insiders 1 | 7.30% |
| % held by institutions 1 | 21.24% |
| Shares short (15 Apr 2024) 4 | 265.28k |
| Short ratio (15 Apr 2024) 4 | 0.71 |
| Short % of float (15 Apr 2024) 4 | 0.38% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.36% |
| Shares short (prior month 15 Mar 2024) 4 | 339.93k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -45.94% |
Management effectiveness
| Return on assets (ttm) | -36.40% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 8.23M |
| Revenue per share (ttm) | 0.13 |
| Quarterly revenue growth (yoy) | 1,822.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -24.78M |
| Net income avi to common (ttm) | -32.48M |
| Diluted EPS (ttm) | -0.5300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 28.92M |
| Total cash per share (mrq) | 0.39 |
| Total debt (mrq) | 43M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.42 |
| Book value per share (mrq) | -0.25 |
Cash flow statement
| Operating cash flow (ttm) | -18.14M |
| Levered free cash flow (ttm) | -17.93M |
© 2024 Yahoo. All rights reserved.